Creo Medical has announced the initiation of phase II of its clinical education programme for its lead product, Speedboat, in the US. This is a significant step, seeing a recently trained US gastrointestinal (GI) endoscopist training three further US clinicians. While Creo itself can train a number of physicians per year, having its trained practitioners running training programmes themselves will create a cascade effect, multiplying the number of trained Speedboat users, and therefore customers ....
10 Sep 2019
Cenkos: Creo Medical Group Plc - Clinician cascade
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Cenkos: Creo Medical Group Plc - Clinician cascade
Creo Medical Group Plc (CREO:LON) | 34.5 0 0.0% | Mkt Cap: 124.7m
- Published:
10 Sep 2019 -
Author:
Chris Donnellan -
Pages:
5
Creo Medical has announced the initiation of phase II of its clinical education programme for its lead product, Speedboat, in the US. This is a significant step, seeing a recently trained US gastrointestinal (GI) endoscopist training three further US clinicians. While Creo itself can train a number of physicians per year, having its trained practitioners running training programmes themselves will create a cascade effect, multiplying the number of trained Speedboat users, and therefore customers ....